spacer
home > epc > winter 2003 > avoiding the pitfalls when completing a crf
PUBLICATIONS
European Pharmaceutical Contractor

Avoiding the Pitfalls when Completing a CRF

In the world of clinical trials, the concept of a CRF is a well-known phenomenon. According to ICH Topic E6, a CRF is "a printed, optical or electronic document designed to record all the protocol requirements to be reported to the sponsor on each trial subject". This definition implies the importance of completing a CRF correctly, as incorrect completion will lead to a misrepresentation of the data of a clinical study, since it is the means of complete data gathering during the trial.

Data collected in a CRF normally include data on the subject/patient, (including demographic and medical history), study drug admission (such as time, dose and method of administration), and the outcome of assessments as described in the protocol and full safety monitoring (adverse events, their seriousness, countermeasures and relationship to drug, for instance). It is of prime importance that these forms be completed correctly as to reflect a true picture of the trial procedures and findings.

Although the CRF is only completed during the clinical trial, its inception is much earlier. Shortly after protocol design, the CRF is drafted and finalised following protocol approval and permission to perform the trial. It can not be stressed enough that when a CRF is being designed, careful attention should be paid to the way provision is made for data capture during the clinical phase. If a CRF is well-designed and its instructions are user-friendly in layout, the correct completion of this important document is effortless and already, many potential errors can be averted.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Cornea Venter, Senior Data Manager, Biometry Division, and Daleen Krige, Medical Writer, Biometry Division, at FARMOVS-PAREXEL

Cornea Venter joined FARMOVS-PAREXEL in 1996 as a Statistical Programmer in the Biometry Division. In 1999 she accepted the position of Data Manager and was promoted to Senior Data Manager in 2001. She holds an Honours degree in Computer Science and has attended several conferences and workshops.


Daleen Krige joined FARMOVS-PAREXEL in 1995 as a Medical Writer in the Biometry Division, after teaching at several education institutions. She holds a Masters degree in Communication Science and is presently researching for a PhD. She attended two European Medical Writers Association (EMWA) conferences in 1996 and 2000.

spacer
Cornea Venter
spacer
spacer
spacer
Daleen Krige
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement